Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer
2017
588 citations
Journal Article
Field-Weighted Citation Impact:
27.71
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer | Researchclopedia
Hao Zhao
·
The University of Texas MD Anderson Cancer Center
Jianfeng Chen
·
The University of Texas MD Anderson Cancer Center
Hong Chen
·
The University of Texas MD Anderson Cancer Center
Eleni Efstathiou
·
The University of Texas MD Anderson Cancer Center
Patricia Troncoso
·
The University of Texas MD Anderson Cancer Center
James P. Allison
·
The University of Texas MD Anderson Cancer Center
Christopher J. Logothetis
·
The University of Texas MD Anderson Cancer Center
Ignacio I. Wistuba
·
The University of Texas MD Anderson Cancer Center
Manuel A. Sepúlveda
·
Johnson & Johnson (United States)
Jingjing Sun
·
The University of Texas MD Anderson Cancer Center
Jennifer A. Wargo
·
The University of Texas MD Anderson Cancer Center
Jorge Blando
·
The University of Texas MD Anderson Cancer Center
Padmanee Sharma
·
The University of Texas MD Anderson Cancer Center